急诊科胸痛患者加速诊断方案实施中的性别与性别因素细节:一项系统综述
该系统综述检索6个电子数据库至2024年5月31日,纳入211项在急诊科实施加速诊断方案(ADP)的成人疑似心源性胸痛研究。95%报告了参与者性别但仅76%报告适当,不足20%在分析或ADP应用中明确考虑性别或社会性别;社会性别报告率仅37%且92%不准确。无研究报告急诊关键结局(如停留时间、会诊、入院、主要不良心脏事件)的性别或社会性别分报告分析,回归分析未发现国际性别政策倡议后报告率显著增加。作者认为急诊心脏研究需一致整合性别因素,未来应研究性别特异性肌钙蛋白切点并报告分报告分析。
要点
- 211项急诊ADP研究中,95%报告参与者性别但仅76%报告适当,不足20%在分析或ADP应用中明确考虑性别或社会性别。
- 社会性别报告率仅37%,且92%报告不准确。
- 无任何研究提供急诊关键结局(停留时间、会诊、入院、主要不良心脏事件)的性别或社会性别分报告分析。
- 回归分析未发现重大国际性别政策倡议后性别/社会性别报告显著增加。
- 作者建议未来研究应检验性别特异性肌钙蛋白切点、调查高危群体并报告急诊相关结局的分报告分析。
适用人群与场景
- 成人疑似心源性胸痛患者,在急诊科环境下接受加速诊断方案(ADP)实施的研究人群。
研究设计与关键结果
- 系统综述纳入211项研究(来自19455条记录),以 prospective cohort 设计为主(39%),87%数据在急诊科收集。
- 95%的研究报告了参与者性别,但仅76%报告适当;不足20%在分析或ADP应用中明确考虑性别或社会性别。
- 社会性别报告率仅37%,且92%报告不准确。
- 无研究报告急诊关键结局(如停留时间、会诊、入院、主要不良心脏事件)的性别或社会性别分报告分析。
- 回归分析未发现重大国际性别政策倡议后性别/社会性别报告显著增加。
证据类型、等级与局限
- 证据类型:系统综述,检索6个电子数据库至2024年5月31日,PROSPERO注册号CRD42022380813。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为急诊心脏研究需改进并一致地整合性别与社会性别因素,因多数研究仅承认性别差异重要性但很少明确处理,更少有意义地考虑社会性别认同的复杂性。
- 作者建议未来研究应检验性别特异性肌钙蛋白切点、调查高危群体并报告急诊相关结局的分报告分析。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Sex and gender influence how chest pain presents, how it is assessed and its outcomes, yet accelerated diagnostic protocols (ADPs) used in emergency departments (EDs) largely ignore these differences. This systematic review assesses the extent to which sex-based and gender-based factors are addressed in studies implementing ADPs in EDs for adult patients presenting with chest pain.
METHODS: Six electronic databases were searched from inception through 31 May 2024, for ED-based studies on ADP implementation in adults with suspected cardiac chest pain. Eligible study designs included randomised controlled trials, controlled clinical trials, cohort studies, before/after studies and observational studies. Two reviewers independently screened articles for relevance and inclusion, with disagreements resolved by third-party adjudication. The primary outcome was the proportion of studies providing sex-disaggregated or gender-disaggregated analyses for key ED outcomes; secondary outcomes included the accuracy of sex and gender reporting per Canadian Institutes of Health Research definitions.
RESULTS: From 19 455 records, 211 studies were included, predominantly prospective cohort designs (39%), with most data collected in ED settings (87%). While 95% reported participant sex, 76% did so appropriately; fewer than 20% considered sex or gender explicitly in their analyses or ADP applications. Gender was reported less frequently (37%) and reporting was largely inaccurate (92%). No studies presented sex-disaggregated or gender-disaggregated analyses for key ED outcomes (eg, length of stay, consultations, admissions, major adverse cardiac events). Regression analyses failed to identify significant increases in sex/gender reporting following major international sex-based and gender-based policy initiatives.
CONCLUSION: Our findings highlight a critical need for improved and consistent integration of sex and gender in ED cardiac research. While most studies recognise the importance of sex differences, few explicitly addressed them, and even fewer considered the complexity of gender identities meaningfully. Future research should examine sex-specific and gender-specific troponin cut points, investigate at-risk groups and report disaggregated analyses of ED-relevant outcomes.
PROSPERO REGISTRATION NUMBER: CRD42022380813.
参考来源
- Essel NOM, Nathoo H, Lesyk N, et al. Sex-based and gender-based details in accelerated diagnostic protocol implementation among emergency department patients presenting with chest pain: a systematic review. Emerg Med J. 2026. PMID: 42309779. doi:10.1136/emermed-2025-215652
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。